7MW3711

DRUG2 trials

Sponsors

Mabwell (Shanghai) Bioscience Co., Ltd.

Conditions

Lung Squamous Cell CarcinomaSolid Tumor

Phase 1

A Phase Ib/II Study of 7MW3711 Combined With JS207 in Advanced Solid Tumors

RecruitingNCT07466160

Mabwell (Shanghai) Bioscience Co., Ltd.Solid Tumor

Start: 2026-02-11End: 2029-12-31Target: 280Updated: 2026-03-12

Phase 3

A Study of 7MW3711 Compared With Docetaxel in Advanced Squamous NSCLC After Prior Chemoimmunotherapy

Not yet recruitingNCT07831863

Mabwell (Shanghai) Bioscience Co., Ltd.Lung Squamous Cell Carcinoma

Start: 2026-10-01End: 2029-12-01Target: 600Updated: 2026-09-21